Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19⁺ Tumors.

ABSTRACT:

SUBMITTER: Grover NS 

PROVIDER: S-EPMC8462586 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature